The platform offers compounded semaglutide if prescribed by a provider.
Tirzepatide
The platform offers compounded tirzepatide if prescribed by a provider.
Trinity Meds is a telehealth/membership layer, not the compounding pharmacy. The site says compounded versions are not FDA approved.
Locations in the source record
A current location was not established by the evidence reviewed.
Services named by sources
Telehealth weight-management membership
Licensed-provider consultations
Prescription coordination
Shipping coordination through pharmacy partners
Regulatory compliance
503 pathway evidence
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Not conclusively established
Trinity Meds presents itself as a telehealth membership platform, not the compounding pharmacy. It names independent pharmacy partners and says compounded prescriptions are prepared by state-regulated 503A pharmacies. No 503A classification is assigned to Trinity Meds itself.
Section 503B
Not conclusively established
No Trinity Meds entity/facility was verified by FDA as a 503B outsourcing facility.
Telehealth providers
No provider relationship is verified in the bound sources.
Clinic Scout links a provider only when an explicit source names the relationship.
FDA and DOJ exact-name searches returned no result. Pharmacy-partner regulatory histories were not duplicated into this platform record; partners are separately identified on Trinity Meds' first-party page.
No regulatory action was found in the bounded search. That is not a categorical absence claim.
Through our healthcare membership, members receive telehealth consultations with licensed providers who may prescribe Compounded Semaglutide or Compounded Tirzepatide if appropriate.
The compounded versions available through the Trinity Meds membership are NOT FDA approved and have not been independently evaluated by the FDA for safety, efficacy, or quality.
Related evidence records
Continue with records sharing source-backed directory tags.
These links are based only on shared GLP-1 relevance or 503-pathway tags; they do not assert affiliation or a dispensing relationship.
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 4 dated first-party or regulator citation(s), 0 regulatory/action record(s), and 7 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
Know when GLP-1 prices move.
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.